ADL BIONATUR SOLUT.EO-,05 Logo
ES0184980003
A1XB95
BST.MC

ADL BIONATUR SOLUT.EO-,05

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2022, ADL BIONATUR SOLUT.EO-,05 has already paid €0.13 in dividends. The last payout was in June 2022.

Financials

In the last quarter, ADL BIONATUR SOLUT.EO-,05 had revenue of €2.11M and net profit of -€1.08M
(EUR) Dec 2025
YoY
Revenue 2.11M -
Gross profit 291.3K -
Net profit -1.08M -
EBITDA 282.36K -

Fundamentals

Metric Value
Market capitalization
€16.34M
Number of shares
74.96M
52-week high/low
€0.48 - €0.18
Dividends No
Beta
1.82
P/E ratio
-8.01
PEG ratio
-0.17
P/B ratio
2.57
P/S ratio
5.29

Company profile

Biotechnologies Assets SA entwickelt und vermarktet biotechnologische Produkte zur Anwendung in der biopharmazeutischen, agrochemischen, kosmetischen, veterinärmedizinischen und chemischen Industrie in Spanien und international. Das Unternehmen wurde 1954 gegründet und hat seinen Sitz in Cádiz, Spanien.

Name
ADL BIONATUR SOLUT.EO-,05
CEO
Manuel Lopez Nieto
Headquarters Cádiz, an
Spain
Website
IPO
01/26/2012
Employees 26

Ticker symbols

Exchange Symbol
Bme
BST.MC
Madrid
BST.MC

Discover assets

Shareholders of ADL BIONATUR SOLUT.EO-,05 also invest in the following assets

🍪

Parqet  uses cookies. Learn more